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Introduction 
The study of the biological correlates of major 
depressive disorder (MDD) has received great 
impetus in recent years. Electroencephalo- 
graphic (EEG) sleep measurements and the Dex- 
amethasone Suppression Test (DST) have been 
among the most studied and productive of these 
biological correlates. Commonly described EEG 
sleep abnormalities in MDD include shortened 
rapid eye movement (REM) latency, increased 
REM density, decreased delta sleep, decreased 
sleep efficiency, and decreased total sleep time 
(Kupfer and Thase 1983; Gillin et al. 1984). 
With EEG sleep measurements, used individ- 
ually or through discriminant analysis, the sen- 
sitivity, specificity, and diagnostic confidence 
for primary endogenous depression ranges from 
61% to 90%, 80% to 100%, and 83% to 100%, 
respectively (Kupfer and Thase 1983). Similar 
findings have been described for the DST in 
MDD (Carroll et al. 1981). Thus, both the sleep 
EEG and the DST can be used to support the 
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clinical diagnosis of MDD with a significant 
degree of confidence. 
A second important application of the bio- 
logical correlates of MDD is in the monitoring 
of the antidepressant treatment response. Nor- 
malization of the DST in patients treated with 
tricyclic antidepressants (Greden et al. 1983) or 
electroconvulsive therapy (ECT) (Albala et al. 
1981) has been shown to occur consistently with 
the clinical improvement of the patients. Sleep 
EEGs, however, have not been used for the 
monitoring of the antidepressant response be- 
cause of the marked effects most psychotropics 
have on sleep EEG measurements (Gillin et al. 
1984). Although preliminary findings (Kupfer 
et al. 1976; Kupfer 1981) suggest that the effects 
of initial dosages of amitriptyline on sleep EEG 
variables can be used to predict antidepressant 
treatment response, these effects of amitripty- 
line may reflect its anticholinergic action rather 
than its antidepressant effects. 
ECT can provide a model with which to study 
the effects of treatment on the sleep EEG mea- 
surements in a setting that is almost devoid of 
the unwanted effects of psychotropic medica- 
tions. When given alone, modified only by very 
short-acting barbiturates, muscle relaxants, and 
quaternary anticholinergics, a course of ECT 
may allow us to monitor the sleep EEG changes 
occurring with clinical improvement. 
We report a case in which serial sleep EEGs 
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and DSTs were used in conjunction with clinical 
depression ratings to monitor the antidepressant 
response to a course of unilateral ECT. The 
changes in the biological correlates paralleled 
those of the clinical measurements and normal- 
ized with treatment. We will discuss previous 
experience with the use of serial sleep EEG in 
the monitoring of the antidepressant response to 
ECT. 
Ca se  R e p o r t  
The patient is a 61-year-old divorced, white fe- 
male with three previous episodes of MDD. The 
current episode of illness began approximately 
1 year before admission. Throughout the year, 
the patient was treated with several antidepres- 
sants without significant clinical response. The 
patient presented symptoms of depressed mood, 
pathologic guilt with associated delusions of 
having caused serious mental illness in one 
daughter and major medical illness in a grand- 
daughter, and crying spells when speaking about 
her family's alleged illnesses. She also had nih- 
ilistic delusions of financial ruin and was con- 
vinced she was unable to continue living be- 
cause of her poor economic situation. She 
complained of middle and terminal insomnia, 
poor appetite, a 10-1b weight loss, lack of en- 
joyment of most of her activities, anergia, and 
mild somatic anxiety, but no hypochondriacal 
symptoms. She described herself as being to- 
tally unfunctional at home, which was con- 
firmed by her family. The patient denied suicidal 
ideation. 
She was diagnosed as having MDD, endog- 
enous subtype with psychotic features, and was 
considered to be a good candidate for ECT. The 
patient received our standard evaluation, in- 
cluding: (1) a 16-day drug-free period, (2) a 
comprehensive medical and psychiatric exami- 
nation, (3) the review of previous medical doc- 
umentation, (4) a Schedule for Affective Dis- 
orders and Schizophrenia (SADS) interview, (5) 
an interview with the family of the patient, and 
(6) joint clinical diagnosis achieved by consen- 
sus between the primary clinician, the SADS 
interviewer, and the senior psychiatrist. 
EEG sleep recordings and the 1-mg overnight 
DST were performed according to the methods 
of Feinberg et al. (1982) and Carroll et al. (1981), 
respectively. A discriminant function (Feinberg 
et al. 1982) based on REM density and REM 
latency was calculated for the patient: a score 
of less than 1 is suggestive of endogenous 
depression. Sleep EEGs were performed on days 
1, 2, 11, 25, 32, 43, and 44, and ECT treatments 
began on day 8 and were given 3 times a week 
for a total of 14 right unilateral treatments. Base- 
line sleep EEGs were performed in the patient's 
own hospital bed after a drug-free period of 16 
days; the serial sleep recordings were performed 
on the second night following the ECT treat- 
ment. The DST was performed once a week, 
with the patient receiving the dexamethasone 
48-72 hr before the sleep EEG recording and 
not on ECT days. The final sleep EEGs were 
performed 3 and 4 days after the last ECT treat- 
ment. The patient did not receive medication 
other than succinylcholine, glycopyrrolate (qua- 
ternary anticholinergic agent), and sodium me- 
thohexital as modifiers of the ECT treatment. 
Resu l t s  
The results presented in Table 1 show that both 
biological correlates were confirmative of the 
MDD diagnosis. The DST was above the 5 ~g/dl 
cutoff line, and the REM latency and discrim- 
inant functions were all well within the de- 
scribed MDD scores. With ECT treatments we 
see a slow but steady decrease in the Hamilton 
Rating Scale for Depression scores (HRSD), in- 
dicating clinical improvement. The changes in 
the sleep measurements began to occur after the 
second ECT treatment. Unfortunately, because 
of technical problems with the sleep recording, 
we were able to obtain only the REM latency 
on this night. At week 6, after 8 ECT treatments, 
both the HRSD scores and the DST remained 
within the "non-normalized" ranges, whereas 
the sleep measurements improved. DST results 
normalized 1 week after the 14th ECT treat- 
ment. Normalization of DST in this patient was 
slower than that described by Albala et al. (1981). 
Other sleep EEG measurements, viz., early 
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Table 1. Serial Monitoring of Sleep EEG and DST and Weekly Depression Ratings in a Psychotic Patient 
Treated with ECT 
C u m u l a t i v e  H i g h e s t  S leep  E E G s  









4 . 4 8  2 5 . 0  - -  - -  - -  
9 . 9 9  22 .5  24 3 .97  ( - - 0 . 3 )  
19 4 .05  ( - 0 . 5 )  
6 . 8 9  19.0 - -  - -  - -  
9 . 9 4  25 .5  39 '~'~ ,~d 
5.01 20 .5  - -  - -  - -  
7 .68  16.0 56 2 .65  I.  1 
13.21 16.0  62 2 .14  1.4 
6 . 3 2  9 . 0  66 2 .05 1.6 
82 2 .53  2 .0  
3 .09  7 .0  - -  - -  - -  
~RL, REM latency. 
bRD, REM density. 
"DF, discriminant function: <1 = endogenous: >1 = nonendogenous. 
d?, Missing data. 
morning awakenings, sleep latency, number of 
arousals, delta sleep, and sleep efficiency, did 
not show significant changes with treatment. 
D i scus s ion  
Serial monitoring of biological correlates of en- 
dogenous depression suggest that it is possible 
to relate the antidepressant treatment response-- 
as measured by rating scales--to biological 
changes. This has been shown to occur with the 
DST during the treatment of melancholic pa- 
tients; the changes in the DST (from non- 
suppression to suppression) correlate with the 
clinical changes (Albala et al. 1981; Greden et 
al. 1983). 
The serial monitoring of antidepressant re- 
sponse with sleep EEG recordings is less fre- 
quently studied because of the effects psycho- 
tropic medications have on sleep measurements. 
Modified ECT may provide a good model in 
which to study the effects of antidepressant 
treatment (ECT) on serial sleep EEG recordings. 
The existing reports on the effects of ECT 
on sleep EEGs all date from 10 to 15 years ago 
and are difficult to interpret. Nevertheless, all 
of the studies (Green and Stajduhar 1966; Hawk- 
ins et al. 1967; Zar~cone et al. 1967; Van de 
Castle and Hawkins 1969; Mendels et al. 1974) 
comment on the beneficial effects of ECT on 
sleep EEG parameters, particularly those of in- 
creased total sleep time, increased stage 4 or 
delta sleep, increased REM sleep, and decreased 
number of awakenings. The effects of ECT on 
REM latency are less clear. Green and Stajduhar 
(1966) reported a case of a psychotically de- 
pressed patient followed with multiple sleep EEG 
recordings and depression rating scales. The au- 
thors reported initial low dream latency and high 
depression ratings. Following a course of ECT, 
the dream latency increased significantly and the 
patient became euthymic. The findings of Green 
and Stajduhar were not confirmed by other au- 
thors (Hawkins et al. 1967; Zarcone et al. 1967; 
Van de Castle and Hawkins 1969; Mendels et 
al. 1974); these discrepancies are probably sec- 
ondary to different sleep scoring methods, and 
more importantly, may be due to the use of REM 
suppressant medications during the recordings. 
Our findings with the serial sleep EEG record- 
ings are similar to those reported by Green and 
Stajduhar 20 years ago. 
In our patient, we show the normalization of 
two biological correlates---sleep EEG and DST-- 
with ECT treatment. Our findings suggest that 
serial monitoring with sleep EEGs in patients 
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with MDD undergoing ECT treatment may be 
of  use and can complement the DST monitoring. 
Before any further comment can be made on 
this use of  the sleep EEG, systematized studies 
need to be done, and these are currently in prog- 
ress in our laboratory. 
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